DLCL.BO BSE
Dr. Lalchandani Labs Ltd.
1W: -7.1%
1M: -11.6%
3M: -13.1%
YTD: -56.6%
1Y: -52.7%
₹6.89 ($0.07)
+0.00 (+0.00%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Cash Flow Trends
Operating Cash Flow
$4M
+303.2% ▲
Capital Expenditures
$2M
-34.5% ▼
5Y CAGR: -24.1%
Free Cash Flow
$3M
+186.6% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
$10M
+224.1% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $14M | $13M | -$16M | $6M | $4M |
| Depreciation & Amort. | $5M | $6M | $7M | $6M | $6M |
| Stock-Based Comp. | $0 | $0 | $0 | $0 | $0 |
| Change in Working Capital | -$6M | -$222K | $280K | -$15M | -$6M |
| Other Non-Cash Items | -$1M | $2M | $9M | $700K | $640K |
| Operating Cash Flow | $12M | $20M | $13K | -$2M | $4M |
| — Investing Activities — | |||||
| Capital Expenditures | -$23M | -$11M | -$3M | -$1M | -$2M |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $0 |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $1M |
| Other Investing | $290K | -$4M | $1M | $11M | $711K |
| Investing Cash Flow | -$23M | -$15M | -$2M | $10M | $587K |
| — Financing Activities — | |||||
| Net Debt Issuance | $19M | $6M | $6M | -$31M | $6M |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | -$2M | -$5M | -$9M | $15M | -$854K |
| Financing Cash Flow | $17M | $2M | -$2M | -$16M | $5M |
| Net Change in Cash | $6M | $6M | -$4M | -$8M | $10M |
| Cash End of Period | $29M | $35M | $31M | $23M | $33M |
| Free Cash Flow | -$11M | $9M | -$3M | -$3M | $3M |